The political, social, and economic health of a nation and the health of its individual people are inextricably linked. Only with citizens of able body and mind can a country hope to build a vibrant, inclusive, and equitable economy and raise living standards.
From product innovation to strengthening health systems, Dalberg works with governments, donors, the private sector, and NGOs to achieve positive outcomes in global health and nutrition in the world’s most underserved regions.
What we do:
Develop policies and strategies to support robust public and private health markets by examining the quality, price, and availability of essential medicines, diagnostics, vaccines and medical technologies, and addressing bottlenecks in health and nutrition programming, procurement, and financing.
Design and advise on innovative financing mechanisms for health and nutrition.
Assist with strategic planning and evaluations, including strategy and business plan development, investment analysis, market landscaping, scale-up strategies, as well as impact evaluations.
Develop policies and programs to strengthen health systems and processes, through program design, capacity building and supply chain management.
Gavi – Strategy for Access to Appropriate Pricing (ATAP) for Vaccines
In order to achieve its mission to increase access to immunization in poor countries, Gavi provides financial and non-financial support to countries to run their vaccination and health systems strengthening programs. In 2015, Gavi was determining how best to help countries that were graduating from its support to smoothly transition to self-financing their own immunization programs. If Gavi financing is suddenly withdrawn, countries run the risk of not being able to procure the tens of millions of vaccines needed to immunize children and prevent life-threatening diseases like polio from returning. Approximately 25 low-income countries currently receiving Gavi financing will graduate to self-financing vaccines by 2020.
Dalberg worked with the Gavi Secretariat and the Gavi Board Committees to determine how best to support access to appropriate vaccine pricing for these Gavi graduated countries, in order to ensure that countries can sustain immunization programs that started with Gavi support, and also continue to introduce new life-saving vaccines.
In collaboration with the Gavi Secretariat, Dalberg led:
An analytic approach to:
• Identify which vaccines were most at risk of increased pricing
• Understand the greatest barriers related to payment for and procurement of vaccines
• Develop and prioritize recommendations that would best address the identified gaps
• Deliver a single solution to support Gavi graduated countries with access to appropriate pricing
Stakeholder engagement with core Gavi partners – including WHO, UNICEF, private sector vaccine manufacturers, other funders such as the Bill and Melinda Gates Foundation, and graduating country government representatives – to ensure all partners were aligned and could provide their own technical input on the final recommended solution.
We recommended that Gavi provide graduated countries access to a mechanism that would include countries in ongoing Gavi/UNICEF tenders for a limited period of time following graduation, and a payment mechanism, UNICEF’s Vaccine Independence Initiative, to provide pre-financing to countries to procure vaccines on a need basis. The Gavi board approved our recommendation in June 2015, which will ensure vaccination of over 10 million children annually.
To learn more about our Global Health and Nutrition work, see our insights or contact:
Erin Barringer, New York
Wouter Deelder, Geneva
Photo credit: Flickr, DFID